JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
Republic Bancorp
RBCAA
$1.82B
| $2.18M | ﹤0.01% |
57,316
-175
| -0.3% | -$7.03K |
2013 Q2
18 quarters
|
|
|
SWCH
3127
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $2.18M | ﹤0.01% |
+119,750
| New | +$2.19M |
2017 Q4
0 quarters
|
|
3128
Provident Financial
PROV
$115M
| $2.17M | ﹤0.01% |
117,948
+32,787
| +39% | +$630K |
2016 Q1
7 quarters
|
|
3129
Integra LifeSciences
IART
$999M
| $2.17M | ﹤0.01% |
45,221
+44,025
| +3,681% | +$2.15M |
2014 Q4
12 quarters
|
|
3130
iShares Core S&P Total US Stock Market ETF
ITOT
$96.7B
| $2.17M | ﹤0.01% |
35,406
+216
| +0.6% | +$12.9K |
2014 Q4
12 quarters
|
|
|
XIN
3131
DELISTED
Xinyuan Real Estate
XIN
| $2.16M | ﹤0.01% |
31,754
+6,007
| +23% | +$353K |
2015 Q4
8 quarters
|
|
3132
CALL
Royal Caribbean
RCL
$74.5B
| $2.16M | ﹤0.01% |
18,100
-19,800
| -52% | -$2.45M |
2016 Q4
4 quarters
|
|
3133
Smith & Wesson
SWBI
$659M
| $2.16M | ﹤0.01% |
218,395
-74,390
| -25% | -$804K |
2015 Q4
8 quarters
|
|
3134
Enova International
ENVA
$4.33B
| $2.15M | ﹤0.01% |
141,681
+116
| +0.1% | +$1.7K |
2015 Q4
8 quarters
|
|
3135
VanEck Junior Gold Miners ETF
GDXJ
$8.3B
| $2.15M | ﹤0.01% |
62,903
+21,580
| +52% | +$704K |
2016 Q2
6 quarters
|
|
3136
ProShares S&P SmallCap 600 Dividend Aristocrats ETF
SMDV
$661M
| $2.15M | ﹤0.01% |
+38,894
| New | +$2.19M |
2017 Q4
0 quarters
|
|
|
FFWM
3137
DELISTED
First Foundation Inc
FFWM
| $2.14M | ﹤0.01% |
115,218
+5,518
| +5% | +$102K |
2016 Q4
4 quarters
|
|
|
AMED
3138
DELISTED
Amedisys
AMED
| $2.13M | ﹤0.01% |
40,404
+30,008
| +289% | +$1.58M |
2015 Q4
8 quarters
|
|
|
MODV
3139
DELISTED
ModivCare
MODV
| $2.12M | ﹤0.01% |
+35,783
| New | +$2.03M |
2017 Q4
0 quarters
|
|
3140
Cable One
CABO
$67.5M
| $2.12M | ﹤0.01% |
3,017
-14,287
| -83% | -$10.1M |
2015 Q3
9 quarters
|
|
|
AY
3141
CALL
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $2.12M | ﹤0.01% |
+100,000
| New | +$2.18M |
2017 Q4
0 quarters
|
|
3142
US Physical Therapy
USPH
$1.26B
| $2.12M | ﹤0.01% |
29,348
+3,100
| +12% | +$211K |
2015 Q4
8 quarters
|
|
3143
Invesco S&P 500 Top 50 ETF
XLG
$11.8B
| $2.12M | ﹤0.01% |
111,540
+2,000
| +2% | +$37K |
2013 Q2
18 quarters
|
|
|
ALOG
3144
DELISTED
Analogic Corp
ALOG
| $2.12M | ﹤0.01% |
25,295
+19,303
| +322% | +$1.6M |
2014 Q4
12 quarters
|
|
3145
Matador Resources
MTDR
$6.58B
| $2.12M | ﹤0.01% |
67,929
+61,879
| +1,023% | +$1.7M |
2015 Q2
10 quarters
|
|
3146
ProShares Investment Grade-Interest Rate Hedged
IGHG
$378M
| $2.11M | ﹤0.01% |
27,378
+26,226
| +2,277% | +$2.02M |
2017 Q1
3 quarters
|
|
3147
News Corp Class B
NWS
$17.1B
| $2.1M | ﹤0.01% |
126,785
+84,427
| +199% | +$1.29M |
2015 Q3
9 quarters
|
|
3148
CALL
eBay
EBAY
$47.1B
| $2.1M | ﹤0.01% |
55,700
-107,800
| -66% | -$4M |
2014 Q3
13 quarters
|
|
|
EXAS
3149
CALL
DELISTED
Exact Sciences
EXAS
| $2.1M | ﹤0.01% |
+40,000
| New | +$2.14M |
2017 Q4
0 quarters
|
|
|
EXAS
3150
PUT
DELISTED
Exact Sciences
EXAS
| $2.1M | ﹤0.01% |
+40,000
| New | +$2.14M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.